SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-08-05
👔
Indivior Pharmaceuticals, Inc.
@INDV_InsiderForm 4 Filing: Anderson Woodrow D Buys $54,420 of $INDV
INSIDER PURCHASE
⚡ MATERIALITY: 6/10
corporate issuer
Indivior Pharmaceuticals, Inc.
Ticker: $INDV
Transaction Value
$54,420
Price/Share: $36.28
transaction date
2026-08-05
Shares: 1,500
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Anderson Woodrow D, holds the title of Chief Accounting Officer at Indivior Pharmaceuticals, Inc..
On 2026-08-05, the insider transacted 1,500 shares.The shares were transacted at a weighted average price of $36.28 per share, resulting in a total market-relevant value of $54,420.
Executive Summary Summary
Anderson Woodrow D (Chief Accounting Officer) bought $54K of $INDV
Post-Transaction Position: 26,138 shares
SEC Accession No: 0002014440-26-000010 (CIK: 2014440)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.